Insider Selling: Imperva CEO Sells 40,000 Shares of Stock (IMPV)
Imperva (NASDAQ:IMPV) CEO Shlomo Kramer unloaded 40,000 shares of the stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $49.99, for a total transaction of $1,999,600.00. Following the transaction, the chief executive officer now directly owns 1,219,521 shares in the company, valued at approximately $60,963,855. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Imperva (NASDAQ:IMPV) traded up 1.63% during mid-day trading on Tuesday, hitting $50.41. The stock had a trading volume of 292,293 shares. Imperva has a 52-week low of $31.87 and a 52-week high of $52.60. The stock has a 50-day moving average of $44.47 and a 200-day moving average of $44.90. The company’s market cap is $1.258 billion.
Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Tuesday, November 5th. The company reported ($0.01) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.05) by $0.04. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $34.43 million. The company’s quarterly revenue was up 33.5% on a year-over-year basis. On average, analysts predict that Imperva will post $-0.13 earnings per share for the current fiscal year.
A number of research firms have recently commented on IMPV. Analysts at Pacific Crest raised their price target on shares of Imperva from $48.00 to $57.00 in a research note to investors on Monday. Separately, analysts at Topeka Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set a “hold” rating on the stock. Finally, analysts at BMO Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set an “outperform” rating and a $52.00 price target on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and eight have issued a buy rating to the stock. Imperva currently has a consensus rating of “Buy” and a consensus target price of $51.89.
Imperva, Inc is a United States-based Company that develops data security solutions for business data in the data center.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.